Export

ATC codes: C09AA02
EMLc
Indication
Essential hypertension ICD11 code: BA00.Z
INN
Enalapril
Medicine type
Chemical agent
List type
Core (EML)
(EMLc)
Formulations
Oral > Liquid: 1 mg per mL (as hydrogen maleate) (EMLc)
Oral > Solid > tablet: 2.5 mg (as hydrogen maleate) ; 5 mg (as hydrogen maleate) ; 10 mg (as hydrogen maleate)
EML status history
First added in 2003 (TRS 920)
Changed in 2009 (TRS 958)
Changed in 2021 (TRS 1035)
Changed in 2023 (TRS 1049)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
Medicines within the same pharmacological class can be used
Therapeutic alternatives limitations
Therapeutic alternatives are medicines in the 4th level ATC chemical subgroup: C09AA ACE inhibitors, plain.
Therapeutic alternatives limitations for EMLc
Therapeutic alternatives are medicines in the 4th level ATC chemical subgroup: C09AA ACE inhibitors, plain.
Patent information
Patents have expired in most jurisdictions
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended the addition of enalapril 10 mg tablets to the EML and EMLc and the addition of enalapril 1 mg/mL oral liquid to the EMLc.